Request a Proposal  
Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
Understanding-COVID-19_ebook_updated-0723-FINAL-1
Phase I Oncology PD-1 Inhibitor Enrolled 78 Days Early
By Ibett Romero
On March 19, 2020

Phase I Oncology PD-1 Inhibitor Enrolled 78 Days Early

Pharm-Olam is a mid-sized, global CRO that provides clinical research solutions for rare diseases, oncology, hematology,...


(1 minute read)

Tags: Pharm-Olam Insights, Oncology-Hematology Disease

Effective Cohort Management in Early Phase Oncology Trials
By Ryan Michalek
On March 11, 2020

Effective Cohort Management in Early Phase Oncology Trials

Cohort management is part and parcel of conducting dose-escalation studies, but not all teams effectively manage it....


(5 minute read)

Tags: Pharm-Olam Insights, Oncology-Hematology Disease

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
GDPR_Checklist-cover